New Study Suggests That Epilepsy Suffers May Have an Increased Risk of Unnatural Death

8 Apr 2018
Tamara Preuschoff
Marketing / Sales

Industry news

Though the risks of dying unnaturally for people with epilepsy are low in absolute terms (0.3-0.5%), they are higher than in people without epilepsy says Dr Hayley Gorton from University of Manchester.

The research conducted at University of Manchester and Swansea University, and funded by the National Institute for Health Research, is published in the journal JAMA Neurology today. The team analyzed data from 44,678 people with epilepsy compared to 891,429 persons without epilepsy in England and 14,051 people with epilepsy compared to 279,365 individuals without epilepsy in Wales. The data shows that compared to people without epilepsy, people with epilepsy are specifically:

  • Twice as likely to die by suicide
  • Three times more likely to die accidentally
  • Five times more likely to die specifically by accidental medication poisoning
  • Three and a half times as likely to die by intentional medication poisoning

Opioid painkillers and medicines for mental illness were most commonly taken in fatal poisonings among people with and without epilepsy, whereas fatal overdoses involving antiepileptic drugs were comparatively rare. Antiepileptic drugs were involved in about 10% of poisoning deaths among people with epilepsy.

Dr Gorton said: “Though unnatural death occurs rarely among all groups in the population, people with epilepsy are almost three times more likely to die from any unnatural cause than those without the condition. “We already know that people with epilepsy are at increased risk of dying prematurely, but such a detailed examination of specific types of unnatural death has not been carried out until now. However, the direct causes of these increased mortality risks are not yet fully understood. And though the paper identifies an association between mortality and epilepsy, we cannot say for certain what causal mechanisms are implicated.”

Dr Gorton added: “Because of these risks, it’s important that people with epilepsy are adequately warned so they can take measures to prevent accidents. We urge clinicians to advise their patients about unintentional injury prevention and monitor them for suicidal thoughts and behavior. We would also advise doctors to assess suitability and toxicity of medication when prescribing medicines for other associated conditions to these individuals.”

Receive the latest news on neuroscience straight to your inbox. Become a free member today.

Links

Tags

Data AnalysisData analysis hardware and software is available to make data processing straight-forward yet powerful. Data software can be used for math and stats, technical graphing and image analysis. In addition, software is available for specific data analysis of electrophoresis, densitometry, ELISA and DNA sequencing.Data MiningData mining is an important process for extracting information, patterns and trends from data. Data mining software, databases, reference materials and storage packages are available to process lab data.Point-of-CarePoint-of-Care Testing (POCT) or Near Patient Testing (NPT) products are available for urine, blood and other clinical chemistry analyses. POCT includes: blood glucose testing, blood gas and electrolytes analysis, rapid coagulation testing (PT / INR), rapid cardiac markers diagnostics, drugs of abuse screening, urine strips testing, pregnancy testing, fecal occult blood analysis, food pathogens screening, hemoglobin diagnostics, infectious disease testing and cholesterol screening.Clinical TrialsClinical Trials, an essential part of drug discovery process, assess the safety and effectiveness of a new medication or device in the pharmaceutical industry. Clinical Trials are a phased process (Phase 0, Phase I, Phase II, Phase III and Phase IV) which begins after initial preclinical testing.NeuroscienceNeuroscience research investigates the neurological mechanisms underlying behavior, neurodegenerative diseases, and other brain conditions. Learn about the innovative technologies for bioimaging, electrophysiology, cell culture, chromatography and other techniques used in this field.Depression